Hong Chen

Title: The Innovations of Hong Chen

Introduction

Hong Chen is a notable inventor based in Chengdu, China. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on VEGFR inhibitors. His research and inventions have the potential to impact the treatment of various diseases.

Latest Patents

Hong Chen holds a patent for a hydrate of a VEGFR inhibitor, specifically a crystal form thereof and a preparation method. The VEGFR inhibitor he developed is 6-(6,7-dimethoxyquinazolin-4-yl-oxy)-N,2-dimethylbenzofuran-3-carboxamide. This invention boasts excellent physicochemical properties, including good flowability, solubility, stability, and bioavailability, while also alleviating hygroscopicity. The preparation method is noted for its simplicity, good repeatability, high yield, and environmental friendliness. It requires only a small amount of solvents, facilitating recycling and effectively reducing reagent costs, which enables easy implementation of large-scale mass production.

Career Highlights

Throughout his career, Hong Chen has worked with prominent companies in the biopharmaceutical sector. He has been associated with Chengdu Easton Biopharmaceuticals Co., Ltd and Chengdu Unovel Biopharma Co., Ltd. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.

Collaborations

Hong Chen has collaborated with several professionals in his field, including Ying Wang and Leixin Wang. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Hong Chen's contributions to the field of biopharmaceuticals, particularly through his patent on VEGFR inhibitors, demonstrate his innovative spirit and commitment to advancing medical science. His work not only showcases his expertise but also holds promise for future developments in the industry.